Got $1,500 to Invest? AbbVie Just Proved the Bull Thesis for Its Stock
At the start of 2023, U.S. patent exclusivity expired for the blockbuster drug Humira, AbbVie's chief cash cow. During the 20 ...
A Better Drug May Make Transplants More Successful
O rgan and cell transplants are potentially life-saving treatments for a variety of medical conditions, but their success ...
Seeking Alpha17d
Eledon: Changing Scope Of Immunosuppressive Drug Space With Tegoprubart
Eledon Pharmaceuticals (NASDAQ:ELDN) completed enrollment of its phase 2 BESTOW trial using its immunosuppressive drug tegoprubart for the prevention of organ rejection in patients who undergo ...